RGNX
Price
$6.33
Change
-$0.34 (-5.10%)
Updated
Apr 4, 04:20 PM (EDT)
Capitalization
334.07M
26 days until earnings call
VANI
Price
$0.95
Change
-$0.04 (-4.04%)
Updated
Apr 4, 02:50 PM (EDT)
Capitalization
58.65M
45 days until earnings call
Ad is loading...

RGNX vs VANI

Header iconRGNX vs VANI Comparison
Open Charts RGNX vs VANIBanner chart's image
REGENXBIO
Price$6.33
Change-$0.34 (-5.10%)
Volume$700
Capitalization334.07M
Vivani Medical
Price$0.95
Change-$0.04 (-4.04%)
Volume$220
Capitalization58.65M
RGNX vs VANI Comparison Chart
Loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGNX vs. VANI commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGNX is a Hold and VANI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (RGNX: $6.67 vs. VANI: $0.99)
Brand notoriety: RGNX and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGNX: 94% vs. VANI: 159%
Market capitalization -- RGNX: $334.07M vs. VANI: $58.65M
RGNX [@Biotechnology] is valued at $334.07M. VANI’s [@Biotechnology] market capitalization is $58.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGNX’s FA Score shows that 1 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • RGNX’s FA Score: 1 green, 4 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, RGNX is a better buy in the long-term than VANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGNX’s TA Score shows that 3 TA indicator(s) are bullish while VANI’s TA Score has 4 bullish TA indicator(s).

  • RGNX’s TA Score: 3 bullish, 7 bearish.
  • VANI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VANI is a better buy in the short-term than RGNX.

Price Growth

RGNX (@Biotechnology) experienced а -15.68% price change this week, while VANI (@Biotechnology) price change was -13.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.13%. For the same industry, the average monthly price growth was -17.00%, and the average quarterly price growth was -18.62%.

Reported Earning Dates

RGNX is expected to report earnings on Apr 30, 2025.

VANI is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-11.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($334M) has a higher market cap than VANI($58.7M). RGNX YTD gains are higher at: -13.713 vs. VANI (-14.655). VANI has higher annual earnings (EBITDA): -24.03M vs. RGNX (-198.23M). RGNX has more cash in the bank: 235M vs. VANI (19.6M). VANI has less debt than RGNX: VANI (19.7M) vs RGNX (82M). RGNX has higher revenues than VANI: RGNX (83.3M) vs VANI (0).
RGNXVANIRGNX / VANI
Capitalization334M58.7M569%
EBITDA-198.23M-24.03M825%
Gain YTD-13.713-14.65594%
P/E RatioN/AN/A-
Revenue83.3M0-
Total Cash235M19.6M1,199%
Total Debt82M19.7M416%
FUNDAMENTALS RATINGS
RGNX vs VANI: Fundamental Ratings
RGNX
VANI
OUTLOOK RATING
1..100
692
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6181
P/E GROWTH RATING
1..100
19100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VANI's Valuation (46) in the null industry is in the same range as RGNX (76) in the Biotechnology industry. This means that VANI’s stock grew similarly to RGNX’s over the last 12 months.

VANI's Profit vs Risk Rating (100) in the null industry is in the same range as RGNX (100) in the Biotechnology industry. This means that VANI’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's SMR Rating (98) in the Biotechnology industry is in the same range as VANI (100) in the null industry. This means that RGNX’s stock grew similarly to VANI’s over the last 12 months.

RGNX's Price Growth Rating (61) in the Biotechnology industry is in the same range as VANI (81) in the null industry. This means that RGNX’s stock grew similarly to VANI’s over the last 12 months.

RGNX's P/E Growth Rating (19) in the Biotechnology industry is significantly better than the same rating for VANI (100) in the null industry. This means that RGNX’s stock grew significantly faster than VANI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RGNXVANI
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
75%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELTK8.20-0.15
-1.80%
Eltek Ltd
ARCO7.99-0.25
-3.03%
Arcos Dorados Holdings
NPCE13.01-0.53
-3.91%
Neuropace
ETN260.85-22.99
-8.10%
Eaton Corp
NE21.08-3.09
-12.78%
Noble Corp

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
-1.98%
VTVT - VANI
60%
Loosely correlated
-0.06%
ADIL - VANI
37%
Loosely correlated
-2.20%
AXSM - VANI
36%
Loosely correlated
-1.69%
RGNX - VANI
34%
Loosely correlated
-5.39%
SCNI - VANI
34%
Loosely correlated
-4.91%
More